Pulmonary Vascular Manifestations of Infectious Diseases
A special issue of Infectious Disease Reports (ISSN 2036-7449). This special issue belongs to the section "Infection Prevention and Control".
Deadline for manuscript submissions: 31 December 2024 | Viewed by 54
Special Issue Editors
Interests: pulmonary vascular disease; viral infections; illicit drug use; endothelial and smooth muscle dysfunction; inflammation
Interests: pulmonary vascular disease; pulmonary hypertension; pulmonary hemodynamics; exercise physiology
Special Issue Information
Dear Colleagues,
Pulmonary vascular diseases are global conditions that are not yet fully understood. In developing nations, infectious diseases, such as schistosomiasis, viral infections, high altitude, hemoglobinopathies, chronic obstructive pulmonary disease, and delayed cardiac management contribute to pulmonary hypertension. Other helminthic diseases, fungal infections, bacterial infections, and tuberculosis have also been implicated. Co-exposure and polyparasitism can be issues in developing countries, as both HIV and schistosomiasis can be found in the same patients. Studying pulmonary manifestations of infection can help understand the role of inflammation and underlying mechanisms to develop new therapies.
This Special Issue of Infectious Disease Reports aims at highlighting future perspectives on the transmission, prevention, and treatment of infection-associated pulmonary vascular disease, while also facilitating the timely publication and dissemination of cutting-edge research. Reviews, case studies, and original research articles are all encouraged. Submissions pertaining to acute- and long-COVID-associated pulmonary complications are welcome.
Prof. Dr. Navneet Kaur Dhillon
Dr. Rudolf K F Oliveira
Prof. Dr. Ghazwan Butrous
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Infectious Disease Reports is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- pulmonary vascular diseases
- pulmonary hypertension
- HIV
- schistosomiasis
- COVID
- post-tuberculosis
- fungus
